alpha-adrenergic antagonist, yohimbe alkaloid · Evidence-based safety and harm-reduction overview.
| Also known as | alpha-adrenergic antagonist, yohimbe alkaloid |
| Category | Nootropic |
| half_life | Roughly 36 minutes in plasma; effects persist longer due to tissue binding |
| peak_onset | 30-90 minutes depending on formulation |
| alpha2_selectivity | More selective for alpha-2 adrenergic receptors than alpha-1, but some alpha-1 activity occurs at higher doses |
| US legal status | Sold as a dietary supplement in the US; FDA does not regulate supplement claims; prescription formulation (yohimbine HCl) available |
An alkaloid from Pausinystalia yohimbe bark that blocks alpha-2 adrenergic receptors, increasing norepinephrine and enhancing arousal and focus.
Yohimbine is a selective alpha-2 adrenergic receptor antagonist. By blocking alpha-2 autoreceptors and heteroreceptors in the brain and periphery, it prevents negative feedback on norepinephrine release, resulting in increased sympathetic tone. This raises norepinephrine and dopamine signaling, enhancing arousal and potentially improving mood and focus.
Yohimbine comes from the bark of Pausinystalia yohimbe, a West African tree used traditionally in sexual and spiritual contexts. The alkaloid was isolated in the 1890s. In the 1980s-2000s, it became popular in Western fitness and supplement markets as a fat-loss and performance enhancer.
Modest evidence for improved mood, focus, and fat mobilization. Effects are mild and variable between individuals. Some controlled studies show benefit; others show minimal difference from placebo.
Prescription yohimbine HCl is typically 2.5-10 mg three times daily. Supplements are poorly standardized; labeled doses range from 500 mg to several grams of extract with highly variable yohimbine alkaloid content (often 1-10 mg per serving or less).
This is general research/context information, not medical advice or a recommended protocol.
Yohimbine is sometimes combined with caffeine for enhanced stimulation, but this significantly amplifies cardiovascular stress. Such stacks carry serious hypertension risk and should only be attempted under medical supervision.
Caffeine with exercise. Caffeine plus regular physical activity delivers alertness and focus with better cardiovascular safety and no hypertension risk.
See our recommended pickIf you are going to research a compound, verifying identity and purity is the single most protective step. Independent analytical testing and sterile-handling supplies reduce risk.
Compare testing optionsQuestionable; long-term safety data are limited. Cardiovascular risks and cumulative effects suggest caution and medical consultation before regular use.
No safe dosing recommendation; effects are individual. Start very low and monitor cardiovascular response. Prescription formulations come with medical guidance.
Marketing drives inclusion more than evidence. Cardiovascular risks are not always mentioned; supplement companies face minimal regulatory scrutiny.
Some evidence exists for mild benefits in mild ED cases. Prescription yohimbine HCl is sometimes used clinically, but efficacy is modest and risks must be weighed.
Natural origin does not guarantee safety. Yohimbine is a potent alkaloid that significantly affects blood pressure and heart rate regardless of source.
Medical & legal disclaimer. This site is for informational and harm-reduction purposes only. It is not medical advice and is not a substitute for a licensed healthcare professional. The compounds discussed are largely not approved by the FDA for human use and many are sold strictly as research chemicals 'not for human consumption.' Nothing here is an endorsement to purchase, possess, or use any substance. Laws vary by jurisdiction. Always consult a qualified physician and follow the law where you live.
Some links on this page may be affiliate links. If you buy through them we may earn a commission at no extra cost to you. This never changes the safety information we publish.